RecruitingNot ApplicableNCT07412522

Serratus Posterior Superior Intercostal Plane Block for Analgesia in Off-Pump Minimally Invasive CABG

Off-pump Minimal Invaziv Koroner Arter Bypass Cerrahisi geçiren Hastalarda Serratus Posterior Superior Interkostal Plan Blokunun Analjezik etkinliği: Randomize kontrollü çalışma


Sponsor

Kartal Kosuyolu High Speciality Training and Research Hospital

Enrollment

60 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Postoperative pain after cardiac surgery is commonly moderate to severe due to sternotomy, thoracotomy, internal mammary artery harvesting, and chest tube placement, and may contribute to adverse systemic and pulmonary outcomes if inadequately managed. Enhanced Recovery After Surgery (ERAS) protocols emphasize opioid-sparing strategies to reduce opioid-related side effects and complications. Ultrasound-guided fascial plane blocks have increasingly been incorporated into perioperative analgesia protocols for cardiac surgery. The serratus posterior superior intercostal plane block (SPSIPB), a recently described technique, provides wide dermatomal sensory coverage and may offer effective analgesia in thoracic and cardiac surgical procedures. This prospective, randomized controlled study aims to evaluate the analgesic efficacy of SPSIPB in adult patients undergoing off-pump minimally invasive coronary artery bypass grafting (CABG). A total of 60 ASA III patients aged 18 years or older will be randomized into two groups: SPSIPB group and control group. The SPSIPB will be performed preoperatively under ultrasound guidance using 0.25% bupivacaine, while the control group will receive standard general anesthesia without any plane block. All patients will receive standardized general anesthesia and postoperative patient-controlled analgesia with tramadol. The primary outcome of the study is postoperative recovery quality assessed using the Quality of Recovery-15 (QoR-15) questionnaire. Secondary outcomes include intraoperative remifentanil consumption, postoperative opioid requirements, time to first rescue analgesia, numerical rating scale (NRS) pain scores at rest and during coughing, extubation time, intensive care unit and hospital length of stay, and postoperative complications such as nausea, vomiting, and atelectasis. This study aims to determine whether SPSIPB can improve postoperative recovery quality and reduce opioid consumption in patients undergoing off-pump minimally invasive CABG.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria5

  • Patients aged 18-75 years
  • ASA physical status II-III
  • Scheduled for elective off-pump minimally invasive coronary artery bypass grafting (CABG) surgery
  • Ability to understand and use the Numerical Rating Scale (NRS)
  • Ability to provide written informed consent

Exclusion Criteria11

  • Refusal to participate in the study
  • Known allergy or contraindication to local anesthetics
  • Coagulation disorders or ongoing anticoagulant therapy incompatible with regional anesthesia
  • Infection at the block injection site
  • Severe hepatic or renal dysfunction
  • Chronic opioid use or opioid dependence
  • History of chronic pain syndromes
  • Severe pulmonary disease (e.g., advanced COPD)
  • Neurological or psychiatric disorders that may interfere with pain assessment
  • Emergency surgery
  • Conversion to on-pump CABG or sternotomy during surgery

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURESerratus Posterior Superior Intercostal Plane Block (SPSIPB)

Ultrasound-guided serratus posterior superior intercostal plane block (SPSIPB) will be performed prior to induction of general anesthesia under sterile conditions. Patients will be positioned laterally with the surgical side up. Using a high-frequency linear ultrasound probe, the scapular spine and the third rib will be identified medial to the scapula. After confirmation of the serratus posterior superior muscle and pleura, the needle will be advanced until contact with the third rib is achieved. Following hydrodissection with 5 mL of isotonic saline, 30 mL of 0.25% bupivacaine (1 mg/kg) will be injected between the serratus posterior superior muscle and the third rib. Cranio-caudal spread of the local anesthetic will be confirmed under ultrasound guidance. All participants will subsequently receive standardized general anesthesia and postoperative analgesia according to the institutional protocol.

DRUGBupivacaine

Bupivacaine was administered as the local anesthetic for the block.

DEVICEUltrasound

Ultrasound guidance was used for block placement.


Locations(1)

Kosuyolu High Specialization Training and Research Hospital

Istanbul, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07412522


Related Trials